Quick Answer
Aprea Therapeutics, Inc. reported Shares Outstanding of 8.19 million shares for fiscal year 2025.
Aprea Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 8.19M | +49.5% |
| 2024 | 5.48M | +46.7% |
| 2023 | 3.74M | +40.7% |
| 2022 | 2.66M | +142.9% |
| 2021 | 1.09M | -94.8% |
| 2020 | 21.19M | +0.8% |
| 2019 | 21.02M | +1719.6% |
| 2018 | 1.16M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 5.98M | +10.0% | +3.9% |
| June 30, 2025 | 5.75M | +5.9% | +4.3% |
| March 31, 2025 | 5.51M | +1.5% | +0.6% |
| December 31, 2024 | 5.48M | +46.7% | +0.8% |
| September 30, 2024 | 5.43M | +45.4% | +0.1% |
| June 30, 2024 | 5.43M | +45.5% | +0.0% |
| March 31, 2024 | 5.43M | +45.5% | +45.3% |
| December 31, 2023 | 3.74M | +40.7% | +0.0% |
- Aprea Therapeutics, Inc. showed an increase of +49.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Aprea Therapeutics, Inc.’s shares outstanding has grown by 609.1% (from 1.16 million shares to 8.19 million shares).
- The most recent figure is from Aprea Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: